Global Cancer Pain Therapeutics Market by Type (Opioids, Non-Steroidal Anti-Inflammatory Drugs, Others), By Application (Paracetamol Treatment-Related Immunotherapy, Radiotherapy, Chemotherapy, Hormone Therapy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

                                          

                                                                                       
Market Overview:

The global cancer pain therapeutics market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of cancer, increasing awareness about pain management, and technological advancements in the field of cancer pain therapeutics. Based on type, the global cancer pain therapeutics market is segmented into opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and others. The opioids segment is expected to dominate the market during the forecast period owing to their high efficacy in managing moderate-to-severe cancer pain. Based on application, the market is segmented into paracetamol treatment-related immunotherapy, radiotherapy, chemotherapy, and hormone therapy.



Get Free Sample Report

Product Definition:

Cancer pain therapeutics are the drugs and treatments used to manage cancer pain. Cancer pain can be caused by the tumor itself, by treatments such as chemotherapy or radiation therapy, or by other health problems related to cancer. Pain relief is an important part of cancer care and can improve quality of life for people with cancer.

Opioids:

Opioids are substances that bind to opioid receptors, which are found in the brain as well as the body. Opioids can produce morphine-like effects when used at high doses. There are two types of opioid receptors: mu and kappa. The mu receptor is primarily located in the central nervous system and is responsible for producing respiratory depression; whereas, kappa receptor is found in the spinal cord and is responsible for producing analgesia (pain relief).

Non-Steroidal Anti-Inflammatory Drugs:

Non-steroidal anti-inflammatory drugs (NSAIDs) are used to reduce the inflammation associated with a wide range of diseases. The most commonly used NSAIDs include aspirin, ibuprofen, and naproxen among others. These drugs act by decreasing the production of prostaglandins which causes pain and other symptoms. Prostaglandins are responsible for causing pain, fever & inflammation amongst other conditions; therefore blocking their production is expected to decrease disease progression.

Application Insights:

Based on application, the market is segmented into paracetamol treatment-related immunotherapy, radiotherapy, chemotherapy and hormone therapy. Paracetamol treatment-related immunotherapy held the largest share in 2017 owing to its usage in various cancer types such as lung cancer and breast cancer. It also reduces the adverse effects of other drugs used for treating these cancers.

Radiotherapy is expected to be one of the fastest growing segments during forecast years due to increasing use of this technique for treating various cancers including prostate cancer and skin melanoma. The availability of advanced imaging techniques such as computerized tomography (CT) helps reduce patient¢â‚¬â„¢s exposure to harmful radiation by a large margin when compared with conventional X-ray imaging techniques used before 2015 worldwide.

Regional Analysis:

North America dominated the global market in 2017. The presence of key players, availability of effective treatment options and high adoption rate for new therapies are some factors responsible for its large share. Moreover, favorable reimbursement policies in this region are also expected to contribute towards its growth over the forecast period.

Asia Pacific is estimated to be the fastest-growing regional market during the forecast period owing to rising incidences of cancer and increasing number of patients seeking treatment options outside China & Japan borders. Furthermore, growing awareness about advanced therapeutics among oncology patients is also expected to drive growth during the projected time frame. In addition, an increase in healthcare expenditure by governments as well as private organizations is further anticipated to boost revenue generation opportunities for key players operating within this space.

Growth Factors:

Rising incidence of cancer: The global incidence of cancer is rising at an alarming rate. This is primarily due to the aging population and the increasing prevalence of lifestyle-related risk factors such as smoking, obesity, and alcohol consumption. According to a study by the World Health Organization (WHO), the number of new cases of cancer is expected to rise from 14 million in 2012 to 22 million by 2030. This will create a large pool of patients who will require treatment for their cancer pain.
Unmet need for better pain relief therapies: Cancer pain continues to be a major challenge for healthcare professionals due to its complex nature and lack of effective treatments. Many patients do not receive adequate relief from existing therapies, which often leads to poor quality of life and increased suffering. There is thus an unmet need for better pain relief therapies that can provide sustained relief without causing any adverse effects.
Growing focus on palliative care: There has been a growing focus on palliative care in recent years as it offers an improved quality of life for terminally ill patients by relieving their symptoms including pain management . Palliative care teams are now being established in hospitals worldwide with the aim of providing holistic care for all patients with advanced cancers . This will help improve access to timely Pain Management Therapy services thereby benefiting more cancer patients globally .


Get Free Sample Report
Scope Of The Report
Report Attributes
Report Details
Report Title
Cancer Pain Therapeutics Market Research Report
By Type
Opioids, Non-Steroidal Anti-Inflammatory Drugs, Others
By Application
Paracetamol Treatment-Related Immunotherapy, Radiotherapy, Chemotherapy, Hormone Therapy
By Companies
BioDelivery Science, ProStrakan Group, Teva pharmaceuticals, Eli-Lilly, Grunenthal Group, GW Pharmaceuticals, Johnson＆Johnson, Meda Pharmaceuticals, Orexo, Sanofi, BioDelivery Science
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.

Global Cancer Pain Therapeutics Market Report Segments:
The global Cancer Pain Therapeutics market is segmented on the basis of:
Types
Opioids, Non-Steroidal Anti-Inflammatory Drugs, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Paracetamol Treatment-Related Immunotherapy, Radiotherapy, Chemotherapy, Hormone Therapy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson＆Johnson
Meda Pharmaceuticals
Orexo
Sanofi
BioDelivery Science



Get Free Sample Report

Highlights of The Cancer Pain Therapeutics Market Report:
The market structure and projections for the coming years.
Drivers, restraints, opportunities, and current trends of market.
Historical data and forecast.
Estimations for the forecast period 2030.
Developments and trends in the market.
By Type:
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
By Application:
Paracetamol Treatment-Related Immunotherapy
Radiotherapy
Chemotherapy
Hormone Therapy
Market scenario by region, sub-region, and country.
Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cancer Pain Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
Correctly Positioning New Products
Market Entry Strategies
Business Expansion Strategies
Consumer Insights
Understanding Competition Scenario
Product & Brand Management
Channel & Customer Management
Identifying Appropriate Advertising Appeals



8 Reasons to Buy This Report
Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
Implemented Robust Methodology to Prepare the Report
Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
Provides Information About the Top-winning Strategies Implemented by Industry Players.
In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
Customization of the Report Available

Frequently Asked Questions?